Entecavir versus lamivudine prophylaxis without hepatitis B immune globulin after liver transplantation for chronic hepatitis B

Oral Presentation - Concurrent Session: Recurrent Disease/Pathology: abstract no. O-126This journal suppl. entitled: Supplement: The ILTS 18th Annual International CongressYoung Investigator Award Winners: James FungBACKGROUND: Oral antiviral prophylaxis without hepatitis B immune globulin (HBIG) has been shown to be effective after liver transplantation for hepatitis B, although the efficacy of different nucleoside/nucleotide analogues is not known. The current study compares the efficacy of entecavir (ETV) versus lamivudine (LAM). PATIENTS AND METHODS: From January 2003 to March 2011, 292 consecutive patients either taking LAM (n=163) or ETV (n=129) as mono-prophylaxis after liver transplantation were included. None of the patients received HBIG …link_to_OA_fulltex